CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Fluorouracil 0.5%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00696488
NCT00696488Phase 4Completed
CompareCT.gov

Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

Wake Forest University·interventional·Posted Jun 12, 2008·Updated Sep 10, 2018

In Brief

A Phase 4 clinical trial evaluating Fluorouracil 0.5% for Actinic Keratosis. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Keratosis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 12, 2008
Enrollment StartApr 1, 2007
Primary CompletionAug 1, 2007
Study CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 18.1 years ago

Interventions

Fluorouracil 0.5%drug

Subjects will apply the smallest amount of study medication possible that is just sufficient to cover all of the affected areas daily to AK lesions